// App-Quantinova.ai

2780 : Genome-wide methylation analysis reveals methylator subtypes of Barrett's esophagus and esophageal adenocarcinoma

Researchers

Presenter

  • Ming Yu

Principal Investigators

  • Sean Maden

  • Andrew Kaz

  • Tai Heinzerling

  • Rachele OLeary

  • Matthew Stachler

  • Adam Bass

  • Amitabh Chak

  • Joseph Willis

  • Sanford Markowitz

  • William Grady

Medical Centers

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Clinical Research Division, Fred Hutchinson Cancer Research Center Department of Medicine, University of Washington School of Medicine Gastroenterology Service, VA Puget Sound Health Care System, Seattle, WA

  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

  • Division of Gastroenterology, Division of Oncology, University Hospitals Case Medical Center, Cleveland, OH

  • Department of Dermatology, University Hospitals Case Medical Center, Cleveland, OH

  • Department of Medicine, University Hospitals Case Medical Center Case Comprehensive Cancer Center, Case Western Reserve University and Case Medical Center, Cleveland, OH

  • Clinical Research Division, Fred Hutchinson Cancer Research Center Department of Medicine, University of Washington School of Medicine, Seattle, WA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

  • Barrett's esophagus

  • Solid malignancies

Biomarkers

  • Tumor protein p53

  • DNA methylation

Drug/Treatment

  • TP53

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A